corner image corner image
                                                                                                                                                 

Home

Sitemap
Saturn BioSciences Ltd
 The Tumour Targeting Company
 
 
   
Home
Team
Construct
Phase 1
Phase 2
Contact
 
 

 

 

  
SAT 012 (huBC1-huIL12) recombinant fusion protein
Tumour Response in phase I study of malignant melanoma
Furthur safety and efficacy data is available here on a poster presented at the American Association of Cancer Research conference.
 
© 2012 Saturn BioSciences